Bioextrax AB (publ) (STO:BIOEX)
Sweden flag Sweden · Delayed Price · Currency is SEK
2.510
-0.030 (-1.18%)
Aug 12, 2026, 3:55 PM CET

Bioextrax AB Financials Overview

Millions SEK. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
1.351.311.013.012.231.03
Revenue Growth
126.60%29.48%-66.40%34.81%116.07%349.97%
Gross Profit
0.190.05-0.421.670.890
Operating Income
-18.18-17.84-17.54-21.6-18.67-10.53
Net Income
-18.05-17.71-17.34-21.51-18.67-10.53
Earnings Per Share
-0.44-0.45-0.52-0.81-1.10-0.79
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash (Debt)
11.563.9317.2713.427.538.98
Net Cash Growth
-4.73%-77.23%28.87%-51.33%206.69%337.54%
Cash & Investments
11.563.9317.2713.427.538.98
Net Cash Per Share
0.280.100.520.511.630.67

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-13.24-26.05-18.78-23.31-17.6-8.48
Capital Expenditures
--0.15-0.22-1.1-6.78-0.98
Free Cash Flow
-13.24-26.2-18.99-24.41-24.38-9.45
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
14.12%3.90%-41.44%55.53%39.74%0.00%
Operating Margin
-1350.59%-1362.80%-1734.82%-717.81%-836.34%-1019.26%
Pretax Margin
-1340.79%-1352.56%-1714.94%-714.76%-836.34%-1019.55%
Profit Margin
-1340.79%-1352.56%-1714.94%-714.76%-836.34%-1019.55%
FCF Margin
-983.51%-2001.38%-1878.64%-811.23%-1092.29%-915.00%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
90.1185.62140.8629.4939.24876.78